Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Senrebotase in idiopathic overactive bladder
NCT01157377Phase 2Completed
- Sponsor
- Allergan
- Start
- Oct 2010
- Primary completion
- Feb 2013
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 3
01
Overview
A Phase 2 trial of senrebotase in overactive bladder (OAB), urinary incontinence (UI), sponsored by Allergan. Started Oct 2010; status: completed.
02
Drugs
senrebotase
03
Conditions
overactive bladder (OAB)urinary incontinence (UI)
Beyond the preview
Go deeper on NCT01157377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01157377.